Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins
US12162926B2 · kind B2 · utility
0Cited by
5References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2021 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Jul 24, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating and for preventing filovirus infections are disclosed, as well as compositions therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.